Plasmin (Grifols)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePlasmin (Grifols)
Drug Alias NameFibrinolysin-human - GrifolsTAL-05-00018BAY-57-9602
ClassificationBiologics > Blood components
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokePeripheral Arterial DiseaseArterial Occlusive Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[15
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsIschemic StrokePeripheral Arterial DiseaseArterial Occlusive Diseases +[4

Other Information

ATC CodeN/A
Related LinksN/A